Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs"

被引:2
|
作者
Su, I-Hsuan [1 ]
Lund, Jennifer L. [1 ,2 ]
Gaber, Charles E. [3 ]
Sanoff, Hanna K. [2 ,4 ]
Strassle, Paula D. [5 ]
Duchesneau, Emilie D. [1 ,2 ]
机构
[1] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[3] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[4] Univ N Carolina, Dept Med, Div Oncol, Chapel Hill, NC 27515 USA
[5] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, NIH, Bethesda, MD USA
来源
ONCOLOGIST | 2023年 / 28卷 / 07期
关键词
BIAS;
D O I
10.1093/oncolo/oyad130
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E588 / E589
页数:2
相关论文
共 50 条
  • [31] Right Versus Left Colon Cancer: Resectable and Metastatic Disease
    Ghidini, Michele
    Petrelli, Fausto
    Tomasello, Gianluca
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (06)
  • [32] Correction: Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma
    Ashley M. Holder
    Jennifer A. Wargo
    Merrick I. Ross
    Annals of Surgical Oncology, 2023, 30 : 7688 - 7688
  • [33] Adjuvant and neoadjuvant chemotherapy for patients with resectable liver metastases from colorectal cancer
    Rougier, P
    Guimbaud, R
    Mitry, E
    Vaillant, JN
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2003, 187 (05): : 881 - 892
  • [34] What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?
    Altorki, Nasser
    Harrison, Sebron
    ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (02) : 167 - 174
  • [35] Academic versus non-academic neurosurgeons in China: a national cross-sectional study on workload, burnout and engagement
    Yu, Jinli
    Gao, Jiming
    Chen, Junyan
    Sun, Yirui
    BMJ OPEN, 2019, 9 (10):
  • [36] Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center
    Yee, Elliott J.
    Gilbert, Danielle
    Kaplan, Jeffrey
    Wani, Sachin
    Kim, Sunnie S.
    McCarter, Martin D.
    Stewart, Camille L.
    CANCERS, 2024, 16 (07)
  • [37] Neoadjuvant chemotherapy and surgery versus surgery alone in resectable esophageal cancer
    Bushan, K.
    Sharma, S.
    INDIAN JOURNAL OF CANCER, 2015, 52 (03) : 413 - 416
  • [38] Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Candidates
    de Angelis, Mario
    Siech, Carolin
    Jannello, Letizia Maria Ippolita
    Di Bello, Francesco
    Penaranda, Natali Rodriguez
    Goyal, Jordan A.
    Touma, Nawar
    Tian, Zhe
    Longo, Nicola
    de Cobelli, Ottavio
    Chun, Felix K. H.
    Micali, Salvatore
    Saad, Fred
    Shariat, Shahrokh F.
    Gandaglia, Giorgio
    Moschini, Marco
    Montorsi, Francesco
    Briganti, Alberto
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [39] Is the combination of neoadjuvant and adjuvant chemotherapy in marginally resectable IIIA non small cell lung cancer (NSCLC) feasible?
    Kolek, Vitezslav
    Grygarkova, I.
    Cwiertka, K.
    Hajduch, M.
    Klein, J.
    Neoral, C.
    ANNALS OF ONCOLOGY, 2006, 17 : 223 - 224
  • [40] Chemotherapy for bladder cancer: Treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer
    Sternberg, Cora N.
    Donat, S. Machele
    Bellmunt, Joaquim
    Millikan, Randall E.
    Stadler, Walter
    De Mulder, Pieter
    Sherif, Amir
    von der Maase, Hans
    Tsukamoto, Taiji
    Soloway, Mark S.
    UROLOGY, 2007, 69 : 62 - 79